Stimulant medication and substance use outcomes ameta-analysis

JAMA Psychiatry

Volumn 70, Issue 7, 2013, Pages 740-749

  Humphreys, Kathryn L ^a   Eng, Timothy ^a   Lee, Steve S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABIS; COCAINE; METHYLPHENIDATE; NICOTINE;

ALCOHOL ABUSE; ALCOHOLISM; ARTICLE; ATTENTION DEFICIT DISORDER; CANNABIS ADDICTION; COCAINE DEPENDENCE; DRUG DEPENDENCE; HUMAN; META ANALYSIS; SENSITIVITY ANALYSIS; SUBSTANCE ABUSE; SYSTEMATIC REVIEW; TOBACCO DEPENDENCE; TREATMENT OUTCOME;

EID: 84880542319     PISSN: 2168622X     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapsychiatry.2013.1273     Document Type: Article

References (50)

1. Greenhill LL, Pliszka S, Dulcan MK, et al; American Academy of Child and Adolescent Psychiatry. Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. J AmAcad Child Adolesc Psychiatry. 2002;41(2)(suppl):26S-49S.
2. O'Brien JM, Felt BT, Van Harrison R, Kochhar PK, Riolo SA. Attention-Deficit Hyperactivity Disorder Guidelines for Clinical Care. Ann Arbor: University of Michigan Health System; 2005.
3. Kollins SH. Comparing the abuse potential of methylphenidate versus other stimulants: a review of available evidence and relevance to the ADHD patient. J Clin Psychiatry. 2003;64(suppl 11):14-18.
4. Kollins SH. A qualitative review of issues arising in the use of psycho-stimulant medications in patients with ADHD and co-morbid substance use disorders. Curr Med Res Opin. 2008;24(5): 1345-1357.
5. Kollins SH, MacDonald EK, Rush CR. Assessing the abuse potential ofmethylphenidate in nonhuman and human subjects: a review. Pharmacol Biochem Behav. 2001;68(3):611-627.
6. Kuczenski R, Segal DS. Stimulant actions in rodents: implications for attention-deficit/hyperactivity disorder treatment and potential substance abuse. Biol Psychiatry. 2005;57(11): 1391-1396.
7. Sax KW, Strakowski SM. Behavioral sensitization in humans. J Addict Dis. 2001;20(3):55-65.
8. Volkow ND, Fowler JS, Wang GJ, Baler R, Telang F. Imaging dopamine's role in drug abuse and addiction. Neuropharmacology. 2009;56(suppl 1): 3-8.
9. Andersen SL, Arvanitogiannis A, Pliakas AM, LeBlanc C, Carlezon WA Jr. Altered responsiveness to cocaine in rats exposed to methylphenidate during development. Nat Neurosci. 2002;5(1):13-14.
10. Brandon CL, Marinelli M, Baker LK, White FJ. Enhanced reactivity and vulnerability to cocaine following methylphenidate treatment in adolescent rats. Neuropsychopharmacology. 2001;25(5): 651-661.
11. Mannuzza S, Klein RG, Truong NL, et al. Age of methylphenidate treatment initiation in children with ADHD and later substance abuse: prospective follow-up into adulthood. Am J Psychiatry. 2008;165(5):604-609.
12. Wilens TE, Faraone SV, Biederman J, Gunawardene S. Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? ameta-analytic review of the literature. Pediatrics. 2003;111(1):179-185.
13. Biederman J, Monuteaux MC, Spencer T, Wilens TE, Macpherson HA, Faraone SV. Stimulant therapy and risk for subsequent substance use disorders in male adults with ADHD: a naturalistic controlled 10-year follow-up study. Am J Psychiatry. 2008;165(5):597-603.
14. Molina BSG, Flory K, Hinshaw SP, et al. Delinquent behavior and emerging substance use in theMTA at 36 months: prevalence, course, and treatment effects. J AmAcad Child Adolesc Psychiatry. 2007;46(8):1028-1040.
15. Golden SM. Does childhood use of stimulant medication as a treatment for ADHD affect the likelihood of future drug abuse and dependence? a literature review. J Child Adolesc Subst Abuse. 2009;18(4):343-358.
16. Mannuzza S, Klein RG, Moulton JL III. Does stimulant treatment place children at risk for adult substance abuse? a controlled, prospective follow-up study. J Child Adolesc Psychopharmacol. 2003;13(3):273-282.
17. Klein RG, Mannuzza S. Children with uncomplicated reading disorders grown up. In: Greenhill LL, ed. Learning Disabilities: Implications for Psychiatric Treatment.Washington, DC: American Psychiatric Press; 2000:1-28.
18. Molina B, PelhamW, Roth J. Stimulant Medication and Substance Use by AdolescentsWith a Childhood History of ADHD. Poster presented at: Biennial Meeting of the International Society for Research in Child and Adolescent Psychopathology; July 16-20, 1999; Barcelona, Spain.
19. Lambert NM. The contribution of childhood ADHD, conduct problems, and stimulant treatment to adolescent and adult tobacco and psychoactive substance abuse. Ethical Hum Psychol Psychiatry. 2005;7(3):197-221.
20. Molina BSG, Pelham WE Jr. Childhood predictors of adolescent substance use in a longitudinal study of children with ADHD. J Abnorm Psychol. 2003;112(3):497-507.
21. Lipsey MW, Wilson DB. Practical Meta-analysis. Thousand Oaks, CA: Sage Publications; 2001.
22. Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. Introduction toMeta-Analysis. Hoboken, NJ:Wiley; 2009.
23. Hedges LV, Olkin I. StatisticalMethods for Meta-Analysis. Orlando, FL: Academic Press; 1985.
24. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629-634.
25. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088-1101.
26. Barkley RA, Fischer M, Smallish L, Fletcher K. Does the treatment of attention-deficit/hyperactivity disorder with stimulants contribute to drug use/abuse? a 13-year prospective study. Pediatrics. 2003;111(1):97-109.
27. Biederman J, Wilens T, Mick E, Spencer T, Faraone SV. Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder. Pediatrics. 1999;104(2):e20.
28. Chilcoat HD, Breslau N. Pathways from ADHD to early drug use. J AmAcad Child Adolesc Psychiatry. 1999;38(11):1347-1354.
29. Cretzmeyer MT. Adolescent ADHD, Stimulant Medication and Adult Substance Abuse [thesis]. Iowa City: University of Iowa School of SocialWork; 2006:71.
30. Harty SC, Ivanov I, Newcorn JH, Halperin JM. The impact of conduct disorder and stimulant medication on later substance use in an ethnically diverse sample of individuals with attention-deficit/hyperactivity disorder in childhood. J Child Adolesc Psychopharmacol. 2011;21(4):331-339.
31. Hechtman L, Weiss G, Perlman T. Young adult outcome of hyperactive children who received long-term stimulant treatment. J AmAcad Child Psychiatry. 1984;23(3):261-269.
32. Huss M. Langfristige Effekte der Methylphenidat-Behandlung auf die Suchtentwicklung bei Kindernmit Aufmerksamkeits-Defizit-Hyperaktivitäts- Störung. Berlin, Germany: Medical Faculty Charité- Universitätsmedizin Berlin; 2005.
33. Huss M, Poustka F, Lehmkuhl G, Lehmkuhl U. No increase in long-term risk for nicotine use disorders after treatment with methylphenidate in children with attention-deficit/hyperactivity disorder (ADHD): evidence from a non-randomised retrospective study. J Neural Transm. 2008;115(2): 335-339.
34. Katusic SK, BarbaresiWJ, Colligan RC, Weaver AL, Leibson CL, Jacobsen SJ. Psychostimulant treatment and risk for substance abuse among young adults with a history of attention-deficit/hyperactivity disorder: a population-based, birth cohort study. J Child Adolesc Psychopharmacol. 2005;15(5):764-776.
35. Lambert NM, Hartsough CS. Prospective study of tobacco smoking and substance dependencies among samples of ADHD and non-ADHD participants. J Learn Disabil. 1998;31(6):533-544.
36. Wilens TE, Adamson J, Monuteaux MC, et al. Effect of prior stimulant treatment for attention-deficit/hyperactivity disorder on subsequent risk for cigarette smoking and alcohol and drug use disorders in adolescents. Arch Pediatr Adolesc Med. 2008;162(10):916-921.
37. Winters KC, Lee S, Botzet A, Fahnhorst T, Realmuto GM, August GJ. A prospective examination of the association of stimulant medication history and drug use outcomes among community samples of ADHD youths. J Child Adolesc Subst Abuse. 2011;20(4):314-329.
38. Lee SS, Humphreys KL, Flory K, Liu R, Glass K. Prospective association of childhood attention-deficit/hyperactivity disorder (ADHD) and substance use and abuse/dependence: a meta-analytic review. Clin Psychol Rev. 2011;31(3): 328-341.
39. Milberger S, Biederman J, Faraone SV, Chen L, Jones J. Further evidence of an association between attention-deficit/hyperactivity disorder and cigarette smoking: findings from a high-risk sample of siblings. Am J Addict. 1997;6(3):205-217.
40. Pelham WE. ADHD treatment with stimulant medication and later substance use. In: Proceedings of the 51st Annual Meeting of the American Academy of Child and Adolescent Psychiatry. Washington, DC: American Academy of Child and Adolescent Psychiatry; 2004.
41. Volkow ND, Swanson JM. Does childhood treatment of ADHD with stimulant medication affect substance abuse in adulthood? Am J Psychiatry. 2008;165(5):553-555.
42. Biederman J, Wilens T, Mick E, et al. Is ADHD a risk factor for psychoactive substance use disorders? findings from a four-year prospective follow-up study. J AmAcad Child Adolesc Psychiatry. 1997;36(1):21-29.
43. Hinshaw SP. Preadolescent girls with attention-deficit/hyperactivity disorder, I: background characteristics, comorbidity, cognitive and social functioning, and parenting practices. J Consult Clin Psychol. 2002;70(5):1086-1098.
44. Larzelere RE, Kuhn BR, Johnson B. The intervention selection bias: an underrecognized confound in intervention research. Psychol Bull. 2004;130(2):289-303.
45. Angold A, Erkanli A, Egger HL, Costello EJ. Stimulant treatment for children: a community perspective. J AmAcad Child Adolesc Psychiatry. 2000;39(8):975-994.
46. Johnston LD, O'Malley PM, Bachman JG, Schulenberg JE. Secondary School Students. Vol I. Ann Arbor: University of Michigan; 2012. Monitoring the Future National Survey Results on Drug Use, 1975-2011.
47. Disney ER, Elkins IJ, McGue M, Iacono WG. Effects of ADHD, conduct disorder, and gender on substance use and abuse in adolescence. Am J Psychiatry. 1999;156(10):1515-1521.
48. Jensen PS, Hinshaw SP, Kraemer HC, et al. ADHD comorbidity findings from the MTA study: comparing comorbid subgroups. J AmAcad Child Adolesc Psychiatry. 2001;40(2):147-158.
49. Swanson JM, Elliott GR, Greenhill LL, et al. Effects of stimulant medication on growth rates across 3 years in the MTA follow-up. J AmAcad Child Adolesc Psychiatry. 2007;46(8):1015-1027.
50. Vitiello B. Methylphenidate in the treatment of children with attention-deficit hyperactivity disorder. CMAJ. 2001;165(11):1505-1506.